KDR and neoplasm: Since anti-VEGF/VEGFR monotherapy is not able to completely suppress tumor angiogenesis, treatment strategies considering multiple perspectives and approaches other than anti-VEGF/VEGFR monotherapy are essential to effectively overcome angiogenesis-induced tumor progression [60].